Screening for the metabolic syndrome in Australia: a national survey of psychiatrists' attitudes and reported practice in patients prescribed antipsychotic drugs.

CONCLUSIONS: Routine screening for metabolic syndrome in patients on antipsychotic agents, by Australian psychiatrists, is inadequate. Interventions to improve screening rates need to be developed, implemented and evaluated. PMID: 26635377 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26635377?dopt=Abstract

Source: Australasian Psychiatry - December 3, 2015 Category: Psychiatry Authors: Laugharne J, Waterreus AJ, Castle DJ, Dragovic M Tags: Australas Psychiatry Source Type: research

More News: Metabolic Syndrome | Psychiatry